Atlas Trials

Carcinoma of the Head and Neck

9 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Carcinoma of the Head and Neck

RecordFirmDate
Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx) (NCT05461430)Travera Inc2022-07-15
Panitumumab-IRDye800 and 89Zr-Panitumumab in Identifying Metastatic Lymph Nodes in Patients With Squamous Cell Head and Neck Cancer (NCT03733210)Andrei Iagaru2019-01-07
Talimogene Laherparepvec With Pembrolizumab for Recurrent Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY232 / KEYNOTE-137) (NCT02626000)Amgen2016-04-06
Accelerated Modulated Fractionation (SIB-IMRT) for Head and Neck District (NCT03001570)European Institute of Oncology2014-01-01
Study of Cetuximab With Concomitant-boost Radiotherapy in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN) (NCT00865098)Merck KGaA, Darmstadt, Germany2009-03-01
Intensity-Modulated Radiotherapy for Recurrent Head and Neck Cancer (NCT00257335)Nilam Ramsinghani2004-10-14
Combination of Taxotere and Oxaliplatin in Squamous Cell Carcinoma of the Head and Neck (NCT00184028)University of Southern California2004-09-01
Phase II Trial of Allovectin-7® for Head and Neck Cancer (NCT00050388)Vical

Track Carcinoma of the Head and Neck automatically

Every clearance here is in the API, with alerts when new ones post.